Low-abundant Adiponectin Receptors in Visceral Adipose Tissue of Humans and Rats Are Further Reduced in Diabetic Animals

Archives of Medical Research

Volumn 41, Issue 2, 2010, Pages 75-82

  Bauer, Sabrina ^a   Weigert, Johanna ^a   Neumeier, Markus ^a   Wanninger, Josef ^a   Schäffler, Andreas ^a   Luchner, Andreas ^a   Schnitzbauer, Andreas A ^a   Aslanidis, Charalampos ^a   Buechler, Christa ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; FENOFIBRATE; MESSENGER RNA; METFORMIN; PALMITIC ACID;

ADIPOCYTE; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPECIES COMPARISON; SUBCUTANEOUS FAT; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; AGED; ANIMALS; ANTILIPEMIC AGENTS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INTRA-ABDOMINAL FAT; MALE; METFORMIN; MICE; MIDDLE AGED; PROCETOFEN; RATS; RATS, ZUCKER; RECEPTORS, ADIPONECTIN;

EID: 77952889478     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.02.010     Document Type: Article

References (44)

1. Kadowaki T., Yamauchi T., Kubota N., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
2. Yamauchi T., Kamon J., Ito Y., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769.
3. Fu Y., Luo N., Klein R.L., et al. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 2005, 46:1369-1379.
4. Otabe S., Yuan X., Fukutani T., et al. Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am J Physiol Endocrinol Metab 2007, 293:E210-E218.
5. Bauche I.B., El Mkadem S.A., Pottier A.M., et al. Overexpression of adiponectin targeted to adipose tissue in transgenic mice: impaired adipocyte differentiation. Endocrinology 2007, 148:1539-1549.
6. Ajuwon K.M., Spurlock M.E. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1220-R1225.
7. Dietze-Schroeder D., Sell H., Uhlig M., et al. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005, 54:2003-2211.
8. Rasmussen M.S., Lihn A.S., Pedersen S.B., et al. Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) 2006, 14:28-35.
9. Fasshauer M., Klein J., Kralisch S., et al. Growth hormone is a positive regulator of adiponectin receptor 2 in 3T3-L1 adipocytes. FEBS Lett 2004, 558:27-32.
10. Ajuwon K.M., Banz W., Winters T.A. Stimulation with peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes. J Inflamm (Lond) 2009, 6:8.
11. Guilherme A., Virbasius J.V., Puri V., et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008, 9:367-377.
12. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29:2959-2971.
13. Nannipieri M., Bonotti A., Anselmino M., et al. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state. Int J Obes (Lond) 2007, 31:1843-1848.
14. Li W., Tonelli J., Kishore P., et al. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle. Am J Physiol Endocrinol Metab 2007, 292:E1301-E1307.
15. Metais C., Forcheron F., Abdallah P., et al. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin. Metabolism 2008, 57:946-953.
16. Kim M.J., Maachi M., Debard C., et al. Increased adiponectin receptor-1 expression in adipose tissue of impaired glucose-tolerant obese subjects during weight loss. Eur J Endocrinol 2006, 155:161-165.
17. Nannipieri M., Cecchetti F., Anselmino M., et al. Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis. Obes Surg 2009, 19:467-474.
18. Tan G.D., Debard C., Funahashi T., et al. Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. Diabetologia 2005, 48:1585-1589.
19. Rodriguez A., Catalan V., Becerril S., et al. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Sci 2008, 83:540-549.
20. Mullen K.L., Pritchard J., Ritchie I., et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 2009, 296:R243-R251.
21. Weigert J., Neumeier M., Wanninger J., Wurm, et al. Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes. FEBS Lett 2008, 582:1777-1782.
22. Neumeier M., Weigert J., Schaffler A., et al. Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochem Biophys Res Commun 2005, 334:924-929.
23. Weigert J., Neumeier M., Bauer S., et al. Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release. FEBS Lett 2008, 582:2965-2972.
24. Schaffler A., Ehling A., Neumann E., et al. Role of specificity protein-1, PPARgamma, and pituitary protein transcription factor-1 in transcriptional regulation of the murine CORS-26 promoter. Biochim Biophys Acta 2004, 1678:150-156.
25. Fredersdorf S., Weil J., Ulucan C., et al. Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats. Naunyn Schmiedebergs Arch Pharmacol 2007, 375:95-103.
26. Neumeier M., Hellerbrand C., Gabele E., et al. Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol 2006, 12:5490-5494.
27. Banga A., Unal R., Tripathi P., et al. Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am J Physiol Endocrinol Metab 2009, 296:E480-E489.
28. Spiegelman B.M., Frank M., Green H. Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem 1983, 258:10083-11009.
29. Schaeffler A., Gross P., Buettner R., et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2008, 126:233-245.
30. Combs T.P., Wagner J.A., Berger J., et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002, 143:998-1007.
31. Perrini S., Laviola L., Cignarelli A., Melchiorre, et al. Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 2008, 51:155-164.
32. Ranganathan G., Li C., Kern P.A. The translational regulation of lipoprotein lipase in diabetic rats involves the 3'-untranslated region of the lipoprotein lipase mRNA. J Biol Chem 2000, 275:40986-40991.
33. Samulin J., Berget I., Lien S., et al. Differential gene expression of fatty acid binding proteins during porcine adipogenesis. Comp Biochem Physiol B Biochem Mol Biol 2008, 151:147-152.
34. Zeigerer A., Rodeheffer M.S., McGraw T.E., et al. Insulin regulates leptin secretion from 3T3-L1 adipocytes by a PI 3 kinase independent mechanism. Exp Cell Res 2008, 314:2249-2256.
35. Barresi V., Grosso M., Giuffre G., et al. The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. J Clin Pathol 2009, 62:705-709.
36. Pinthus J.H., Kleinmann N., Tisdale B., et al. Lower plasma adiponectin levels are associated with larger tumor size and metastasis in clear-cell carcinoma of the kidney. Eur Urol 2008, 54:866-873.
37. Yoneda K., Tomimoto A., Endo H., et al. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol Rep 2008, 20:479-483.
38. Ishikawa M., Kitayama J., Kazama S., et al. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005, 11:466-472.
39. Toyoda T., Kamei Y., Kato H., et al. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity (Silver Spring) 2008, 16:1199-1207.
40. Yessoufou A., Ategbo J.M., Attakpa E., et al. Peroxisome proliferator-activated receptor-alpha modulates insulin gene transcription factors and inflammation in adipose tissues in mice. Mol Cell Biochem 2009, 323:101-111.
41. Permana P.A., Zhang W., Wabitsch M., et al. Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages. Am J Physiol Endocrinol Metab 2009, 296:E1076-E1084.
42. Ohman M.K., Wright A.P., Wickenheiser K.J., et al. Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol 2009, 7:169-179.
43. Walker C.G., Sugden M.C., Gibbons G.F., et al. Peroxisome proliferator-activated receptor alpha deficiency modifies glucose handling by isolated mouse adipocytes. J Endocrinol 2007, 193:39-43.
44. Jeong S., Yoon M. Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese mice. Exp Mol Med 2009, 30:397-405.